INCY - Incyte Corporation

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
61,04
-0,47 (-0,76%)
Alla chiusura: 04:00PM EDT
61,04 0,00 (0,00%)
Dopo ore: 07:47PM EDT
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente61,51
Aperto61,34
Denaro60,00 x 800
Lettera62,31 x 1000
Min-Max giorno60,73 - 61,76
Intervallo di 52 settimane60,61 - 86,29
Volume1.493.279
Media Volume1.697.760
Capitalizzazione13,722B
Beta (5 anni mensile)0,72
Rapporto PE (ttm)42,69
EPS (ttm)1,43
Prossima data utili31 lug 2023 - 04 ago 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A82,24
  • GlobeNewswire

    Knight Therapeutics Announces Regulatory Submission for Tafasitamab in Brazil

    MONTREAL, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for tafasitamab in combination with lenalidomide to ANVISA, the Brazilian health regulatory agency, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for auto